Senti Biosciences Holdings, Inc.
Senti Biosciences Holdings, Inc. financial statements
Senti Biosciences Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 22K | 10-K |
| Net income | −USD 61.44M | 10-K |
| Cash and equivalents | USD 16.42M | 10-Q |
| Total debt | USD 28.89M | EODHD |
Senti Biosciences Holdings, Inc. financials on 6ix · Senti Biosciences Holdings, Inc. on 6ix